Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS)

CNY 18.59

(-0.37%)

Market Cap (In CNY)

26.93 Billion

Revenue (In CNY)

8.21 Billion

Net Income (In CNY)

830.46 Million

Avg. Volume

11.16 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
10.71-21.55
PE
-
EPS
-
Beta Value
0.091
ISIN
CNE000001DL5
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Bao Hua Chen
Employee Count
-
Website
https://www.huahaipharm.com
Ipo Date
2003-03-04
Details
Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also engages in packaging components business, such as high-density polyethylene bottles and polypropylene caps. In addition, the company provides contract manufacturing and other services. Further, it is involved in import and export trade services. Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.